Keensight hires two operating partners

Moses is the former CEO of Ablynx, a biopharmaceutical company acquired by Sanofi in 2018 for €3.9bn. Prior to Ablynx, he was the CEO of OAI (Oxford Asymmetry International), a clinical research organisation acquired by Evotec in 2000 for $475m.

Martín is the former CFO, senior vice-president and board member of Werfen, an in-vitro diagnostics business headquartered in Barcelona and present in 25 countries.

Moses will be based in Belgium while Martín will be located in Spain, with both adding to Keensight's existing team of international operating partners.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• People
• France
• Benelux
• Southern Europe
• GPs
• Keensight Capital
• people moves